Research Bio
A board certified neurologist with specialty training in neuro-oncology, Dr. Nimish Mohile completed his residency in neurology at Northwestern University followed by a fellowship in neuro-oncology at Memorial Sloan-Kettering Cancer Center. Dr. Mohile joined the faculty at the University of Rochester in 2007 where he has a joint appointment in neurology and oncology. He sees patients at the James P. Wilmot Cancer Center and at Strong Memorial Hospital.
Dr. Mohile sees patients with primary and metastatic brain tumors and is involved in administering chemotherapy, treating seizures and managing side effects of brain tumors and brain tumor therapy. In addition, he does consultations on patients with neurologic complications of cancer or cancer treatments.
His research focuses on understanding the role of cancer stem cells in the progression of brain tumors. He is interested in developing novel therapies for the treatment of all types of brain tumors and is currently the principal investigator of several clinical trials at the University of Rochester.
| Neurology Faculty Teaching Award | University of Rochester | Rochester, NY |
2011 |
| SWOG Travel Award Recipient | Souhwest Oncology Group |
2011 |
| American Neurological Association Junior Academic Scholarship Award |
2009 |
| American Society of Clinical Oncology Foundation Merit Award | American Society of Clinical Oncology Foundation |
2007 |
| Graduate Medical Education Award for excellence in teaching medical students |
2004 |
| AAN Resident Annual Meeting Scholarship | American Academy of Neurology |
2004 |
| Dean's List | St George's University | Grenada, WI |
1996 - 2000 |
| Dean's List | Duke University | Chapel Hill, NC |
1994 |
2011 Mar 29
Mohile NA, Zoccoli CM, Glantz M. "Is brain the new bone marrow? Stem cells, cancer, and cognition: a working hypothesis." Neurology. 2011 Mar 29; 76(13):1118-20. Epub 2011 Feb 23. |
2010 Nov 15
Milano MT, Okunieff P, Donatello RS, Mohile NA, Sul J, Walter KA, Korones DN. "Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma." International journal of radiation oncology, biology, physics. 2010 Nov 15; 78(4):1147-55. Epub 2010 Mar 06. |
2010 May
Milano MT, Johnson MD, Sul J, Mohile NA, Korones DN, Okunieff P, Walter KA. "Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database study." Journal of neuro-oncology. 2010 May 0; 98(1):83-92. Epub 2009 Nov 07. |
2009 Sep 1
Gutin PH, Iwamoto FM, Beal K, Mohile NA, Karimi S, Hou BL, Lymberis S, Yamada Y, Chang J, Abrey LE. "Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas." International journal of radiation oncology, biology, physics. 2009 Sep 1; 75(1):156-63. Epub 2009 Jan 23. |
2008 Nov
Mohile NA, Deangelis LM, Abrey LE. "Utility of brain FDG-PET in primary CNS lymphoma." Clinical advances in hematology & oncology : H&O. 2008 Nov 0; 6(11):818-20, 840. |
